Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit
Study shows patients taking abatacept, cenicriviroc, or Remicade in addition to SOC do not recover quicker compared to placebo.
CSL Behring
Healthcare Products
Subscribed
You have successfully submitted your enquiry. Someone from our company will respond ASAP
About Us
CSL Behring GmbH (CSL Behring), formerly Aventis Behring GmbH, a subsidiary of CSL Ltd, offers a wide range of healthcare products which is derived from plasma protein biotherapeutics. The company provide products for coagulation disorders, immunoglobulins, chronic inflammatory demyelinating polyneuropathy, hereditary angioedema, haemophilia, alpha1-antitrypsin deficiency and immunodeficiencies. It offers patients different drugs based on plasma, a recombinant factor VIII and a fibrinolytic agent. CSL Behring conducts research in partnership with various academic institutions and organizations to develop plasma and recombinant products. CSL Behring GmbH is headquartered in Marburg, Germany.
Company Insights
Contact Details
Website
Address
Emil-Von-Behring-Strasse 76, Marburg, Hessen, 35041,
Germany
Germany
Phone
Regional Offices
Address
CSL Behring
Emil-Von-Behring-Strasse 76, Marburg, Hessen, 35041
Germany